R01FY2026TricuspidRepair
$428K Intracardiac beating heart tricuspid valve repair via robotics.Summary
About 2.5% of the US population has a valvular heart disease. While neglected for a long time, problems related
to the tricuspid valve affect more than 70 million people worldwide. Among these, more than 1.6 million are in the
US. The yearly incidence is about 200,000 with a 1-year mortality rate of 36.1%.
The most common problem is tricuspid valve regurgitation. The majority of tricuspid regurgitation cases are treated
surgically via prosthetic ring annuloplasty in open surgery. However, open surgery approaches introduce risks of
perioperative complications and require long recovery times. A large percentage of the population with tricuspid
regurgitation cannot receive surgical treatment because of the high-risk profile. Few patients undergo isolated
tricuspid valve surgery because the challenging anatomy of the tricuspid valve and lack of clinical experience has
hindered progress in this area.
Therefore, there is a clinical need for novel approaches that would allow tricuspid